CXCL17 Expression by Tumor Cells Recruits CD11b+Gr1highF4/80- Cells and Promotes Tumor Progression

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Matsui, Aya ^a,b   Yokoo, Hideaki ^c   Negishi, Yoichi ^d   Endo Takahashi, Yoko ^d   Chun, Nicole A L ^b   Kadouchi, Ichiro ^b   Suzuki, Ryo ^e   Maruyama, Kazuo ^e   Aramaki, Yukihiko ^e   Semba, Kentaro ^f   Kobayashi, Eiji ^b   Takahashi, Masafumi ^b   Murakami, Takashi ^a  

^a TAKASAKI UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^e TEIKYO UNIVERSITY   (Japan)

^f WASEDA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD31 ANTIGEN; CHEMOKINE; CHEMOKINE CXCL17; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELLULAR DISTRIBUTION; COLON CANCER; CONTROLLED STUDY; EXPERIMENTAL MOUSE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, LY; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHEMOKINES, CXC; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MYELOID CELLS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NIH 3T3 CELLS; RNA, MESSENGER;

MUS;

EID: 84865608539     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044080     Document Type: Article

References (37)

1. Mantovani A, Allavena P, Sica A, Balkwill F, (2008) Cancer-related inflammation. Nature 454: 436-444.
2. Hanahan D, Folkman J, (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.
3. Bergers G, Benjamine LE, (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3: 401-410.
4. Murdoch C, Muthana M, Coffelt SB, Lewis CE, (2008) The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8: 618-631.
5. Mishra PJ, Mishra PJ, Glod JW, Banerjee D, (2009) Mesenchymal stem cells: flip side of the coin. Cancer Res 69: 1255-1258.
6. Gabrilovich DI, Nagaraj S, (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9: 162-174.
7. Balkwill F, (2004) Cancer and the chemokine network. Nat Rev Cancer 4: 540-550.
8. Wang JM, Taraboletti G, Matsushima K, Van Damme J, Mantovani A, (1990) Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8. Biochem Biophys Res Commun 169: 165-170.
9. Yanagawa J, Walser TC, Zhu LX, Hong L, Fishbein MC, et al. (2009) Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma. Clin Cancer Res 15: 6820-6829.
10. Pisabarro MT, Leung B, Kwong M, Corpuz R, Frantz GD, et al. (2006) Novel human dendritic cell- and monocyte-attracting chemokine-like protein identified by fold recognition methods. J Immunol 176: 2069-2073.
11. Weinstein EJ, Head R, Griggs DW, Sun D, Evans RJ, et al. (2006) VCC-1, a novel chemokine, promotes tumor growth. Biochem Biophys Res Commun 350: 74-81.
12. Sun H, Taneja R, (2007) Analysis of transformation and tumorigenicity using mouse embryonic fibroblast cells. Methods Mol Biol 383: 303-310.
13. Sato A, Ohtsuki M, Hata M, Kobayashi E, Murakami T, (2006) Antitumor activity of interferon (IFN)-lambda in murine tumor models. J Immunol 176: 7686-7694.
14. Conti I, Rollins BJ, (2004) CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol 14: 149-154.
15. Mishra P, Banerjee D, Ben-Baruch A, (2011) Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy. J Leukoc Biol 89: 31-39.
16. Fridlender ZG, Buchlis G, Kapoor V, Cheng G, Sun J, et al. (2010) CCL2 blockade augments cancer immunotherapy. Cancer Res 70: 109-118.
17. Copeland NG, Cooper GM, (1979) Transfection by exogenous and endogenous murine retrovirus DNAs. Cell 16: 347-356.
18. Fujita J, Yoshida O, Yuasa Y, Rhim JS, Hatanaka M, et al. (1984) Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours. Nature 309: 464-466.
19. Whitehead IP, Zohn IE, Der CJ, (2001) Rho GTPase-dependent transformation by G protein-coupled receptors. Oncogene 20: 1547-1555.
20. Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, et al. (1998) G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator Nature. 391: 86-9.
21. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A, (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555.
22. Balkwill F, Coussens LM, (2004) Cancer: an inflammatory link. Nature 431: 405-406.
23. Luo Y, Zhou H, Krueger J, Kaplan C, Lee SH, et al. (2006) Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest 116: 2132-2141.
24. Tadmor T, Attias D, Polliack A, (2011) Myeloid-derived suppressor cells-their role in haemato-oncological malignancies and other cancers and possible implications for therapy. Br J Haematol 153: 557-567.
25. Hiraoka N, Yamazaki-Itoh R, Ino Y, Mizuguchi Y, Yamada T, et al. (2011) CXCL17 and ICAM2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis. Gastroenterology 140: 310-321.
26. Kusmartsev S, Nagaraj S, Gabrilovich DI, (2005) Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells. J Immunol 175: 4583-4592.
27. Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, et al. (2009) Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 16: 183-194.
28. Andrae J, Gallini R, Betsholtz C, (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22: 1276-1312.
29. Holmqvist K, Cross MJ, Rolny C, Hägerkvist R, Rahimi N, et al. (2004) The adaptor protein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-dependent cellular migration. J Biol Chem 279: 22267-22275.
30. Poole TJ, Finkelstein EB, Cox CM, (2001) The role of FGF and VEGF in angioblast induction and migration during vascular development. Dev Dyn 220: 1-17.
31. Mantovani A, (2009) The yin-yang of tumor-associated neutrophils. Cancer Cell 16: 173-174.
32. Lazennec G, Richmond A, (2010) Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 16: 133-144.
33. Murakami T, Maki W, Cardones AR, Fang H, Tun Kyi A, et al. (2002) Expression of CXC chemokine receptor (CXCR)-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res 62: 7328-7334.
34. Yanagisawa S, Kadouchi I, Yokomori K, Hirose M, Hakozaki M, et al. (2009) Identification and metastatic potential of tumor-initiating cells in malignant rhabdoid tumor of the kidney. Clin Cancer Res 5: 3014-3022.
35. Morgenstern JP, Land H, (1990) Advanced mammalian gene transfer: high titer retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res 18: 3587-3596.
36. Murakami T, Sato A, Chun NAL, Hara M, Naito Y, et al. (2008) Transcriptional modulation using HDACi depsipeptide promotes immune cell-mediated tumor destruction of murine B16 melanoma. J Invest Dermatol 28: 1506-1516.
37. Negishi Y, Endo Y, Fukuyama T, Suzuki R, Takizawa T, et al. (2008) Delivery of siRNA into the cytoplasm by liposomal bubbles and ultrasound. J Control Release 132: 124-130.